ArticleScientific reports2016

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer.

Yumin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.